Topoisomerase II: a potential target for novel antifungal agents

Biochem Biophys Res Commun. 1989 Apr 14;160(1):257-62. doi: 10.1016/0006-291x(89)91649-5.

Abstract

Several podophyllotoxin-related lignans have been shown to possess significant antifungal activity against a number of filamentous fungi. Initial structure-activity studies indicate this action is sensitive to change at the 4 and 4' positions of the podophyllotoxin skeleton. Good correlation has been observed between antifungal action and the ability to inhibit the relaxation of supercoiled plasmid DNA by a topoisomerase II preparation from Saccharomyces cerevisiae. Etoposide, an inhibitor of mammalian topoisomerase II, is inactive against this yeast enzyme, although good inhibition is shown by amiloride, 4'-(9-acridinylamino)-methanesulphon-m-anisidide (m-AMSA) and novobiocin, known inhibitors of the mammalian enzyme.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amiloride / pharmacology
  • Amsacrine / pharmacology
  • Antifungal Agents
  • DNA, Superhelical / metabolism
  • Etoposide / pharmacology
  • Molecular Structure
  • Novobiocin / pharmacology
  • Plasmids
  • Podophyllotoxin / analogs & derivatives*
  • Podophyllotoxin / pharmacology
  • Saccharomyces cerevisiae / enzymology*
  • Structure-Activity Relationship
  • Topoisomerase II Inhibitors*

Substances

  • Antifungal Agents
  • DNA, Superhelical
  • Topoisomerase II Inhibitors
  • Amsacrine
  • Novobiocin
  • Etoposide
  • Amiloride
  • Podophyllotoxin